1 – 13 of 13
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Agreement of the modified Medical Research Council and New York Heart Association scales for assessing the impact of self-rated breathlessness in cardiopulmonary disease
(
- Contribution to journal › Article
- 2021
-
Mark
Minimal clinically important differences for Dyspnea-12 and MDP scores are similar at 2 weeks and 6 months : follow-up of a longitudinal clinical study
(
- Contribution to journal › Letter
- 2020
-
Mark
Minimal Clinically Important Differences and Feasibility of Dyspnea-12 and the Multidimensional Dyspnea Profile in Cardiorespiratory Disease
(
- Contribution to journal › Article
- 2019
-
Mark
Validation of the Swedish Multidimensional Dyspnea Profile (MDP) in outpatients with cardiorespiratory disease
(
- Contribution to journal › Article
-
Mark
Clinical validation of the Swedish version of Dyspnoea-12 instrument in outpatients with cardiorespiratory disease
(
- Contribution to journal › Article
-
Mark
REgistry-based randomized controlled trial of treatment and Duration and mortality in long-term OXygen therapy (REDOX) study protocol 11 Medical and Health Sciences 1102 Cardiorespiratory Medicine and Haematology
(
- Contribution to journal › Article
- 2018
-
Mark
Spirometric volumes and breathlessness across levels of airflow limitation : The CopDGene study
(
- Contribution to journal › Letter
- 2016
-
Mark
Cardiovascular and antacid treatment and mortality in oxygen-dependent pulmonary fibrosis : A population-based longitudinal study
(
- Contribution to journal › Article
-
Mark
Long-term oxygen therapy 24 vs 15 h/day and mortality in chronic obstructive pulmonary disease
(
- Contribution to journal › Article
-
Mark
Oxygen for breathlessness in patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy
(
- Contribution to journal › Scientific review
- 2015
-
Mark
Low-dose opioids should be considered for symptom relief also in advanced chronic obstructive pulmonary disease (COPD).
(
- Contribution to journal › Article
- 2014
-
Mark
Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study.
(
- Contribution to journal › Article
-
Mark
Hypo- and hypercapnia predict mortality in oxygen-dependent chronic obstructive pulmonary disease: a population-based prospective study
(
- Contribution to journal › Article